FCAS
First Command Advisory Services’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31.2K | Hold |
70
| – | – | ﹤0.01% | 325 |
|
|
2025
Q1 | $33.9K | Buy |
70
+10
| +17% | +$4.85K | ﹤0.01% | 308 |
|
|
2024
Q4 | $24.2K | Hold |
60
| – | – | ﹤0.01% | 333 |
|
|
2024
Q3 | $27.9K | Hold |
60
| – | – | ﹤0.01% | 325 |
|
|
2024
Q2 | $28.1K | Sell |
60
-3,237
| -98% | -$1.52M | ﹤0.01% | 299 |
|
|
2024
Q1 | $308K | Buy |
3,297
+3,237
| +5,395% | +$302K | ﹤0.01% | 127 |
|
|
2023
Q4 | $24.4K | Hold |
60
| – | – | ﹤0.01% | 292 |
|
|
2023
Q3 | $20.9K | Buy |
+60
| New | +$20.9K | ﹤0.01% | 297 |
|
|
2023
Q2 | – | Sell |
-7
| Closed | -$2.21K | – | 175 |
|
|
2023
Q1 | $2.21K | Buy |
+7
| New | +$2.21K | ﹤0.01% | 57 |
|